Hatzigeorgiou D E, He S, Sobel J, Grabstein K H, Hafner A, Ho J L
Department of Medicine, Cornell University Medical College, New York, NY 10021.
J Immunol. 1993 Oct 1;151(7):3682-92.
IL-6 is a cytokine synthesized by T cells and macrophages (M phi). It has pleiotropic effects on diverse cell types and is recognized for its "pro-inflammatory" properties. In mice, IL-4, IL-5, IL-6, and IL-10 are produced by Th-2 cells. Because IL-10 suppresses Th-1 clones, and IL-4 broadly deactivates M phi, experiments were carried out to investigate the in vitro effects of recombinant human IL-6 on cytokine activation of human M phi. Pretreatment with IL-6 induced a dose- and time-dependent suppression of IFN-gamma (1000 U/mL) and TNF-alpha (25 ng/mL) activation of M phi for the killing of L. amazonensis. At doses greater than 0.1 to 100 ng/mL, IL-6 inhibited IFN-gamma and TNF-alpha activation by 21 to 93% and 36 to 82%, respectively. IL-6 alone had no effect on M phi viability and intracellular L. amazonensis growth. Blockade of M phi activation was greatest when IL-6 was added 24 or 48 h before infection and treatment with IFN-gamma or TNF-alpha. Furthermore, mAb against IL-6 abrogated the inhibitory activity of IL-6. Similarly IL-6 pretreatment suppressed M phi activation for antileishmanial capacity by IL-3, granulocyte-monocyte-CSF (GM-CSF) and IL-1 beta. Because cytokine induction of antileishmanial activity is associated with enhancement of oxidative capacity, the effect of IL-6 on this mechanism was evaluated. Pretreatment with IL-6 down-modulated TNF-alpha (25 ng/mL) enhancement of M phi oxidative capacity in a dose- and time-dependent manner. A similar depression of oxidative capacity was observed for GM-CSF and IL-3 but not for IFN-gamma. Furthermore, NG-monomethyl-L-arginine (a nitric oxide synthase inhibitor) had no effect on IFN-gamma and TNF-alpha activation of antileishmanial activity and nitrites/nitrates were not reliably assayed from M phi culture supernatants. These findings suggest that IL-6 down-modulates cytokine activation of M phi antileishmanial capacity by inhibiting oxygen-dependent and undefined oxygen-independent mechanisms.
白细胞介素-6(IL-6)是一种由T细胞和巨噬细胞(M phi)合成的细胞因子。它对多种细胞类型具有多效性作用,并因其“促炎”特性而被认可。在小鼠中,IL-4、IL-5、IL-6和IL-10由Th-2细胞产生。由于IL-10抑制Th-1克隆,且IL-4广泛使M phi失活,因此进行了实验以研究重组人IL-6对人M phi细胞因子激活的体外作用。用IL-6预处理可诱导对M phi杀伤亚马逊利什曼原虫的干扰素-γ(1000 U/mL)和肿瘤坏死因子-α(25 ng/mL)激活的剂量和时间依赖性抑制。在大于0.1至100 ng/mL的剂量下,IL-6分别将干扰素-γ和肿瘤坏死因子-α的激活抑制21%至93%和36%至82%。单独的IL-6对M phi活力和细胞内亚马逊利什曼原虫生长没有影响。当在感染以及用干扰素-γ或肿瘤坏死因子-α处理前24或48小时加入IL-6时,对M phi激活的阻断作用最大。此外,抗IL-6单克隆抗体消除了IL-6的抑制活性。同样,IL-6预处理抑制了IL-3、粒细胞-单核细胞集落刺激因子(GM-CSF)和IL-1β对M phi抗利什曼原虫能力的激活。由于抗利什曼原虫活性的细胞因子诱导与氧化能力增强相关,因此评估了IL-6对该机制的影响。用IL-6预处理以剂量和时间依赖性方式下调肿瘤坏死因子-α(25 ng/mL)对M phi氧化能力的增强作用。对于GM-CSF和IL-3观察到了类似的氧化能力降低,但对于干扰素-γ则未观察到。此外,NG-单甲基-L-精氨酸(一种一氧化氮合酶抑制剂)对干扰素-γ和肿瘤坏死因子-α的抗利什曼原虫活性激活没有影响,并且从M phi培养上清液中未能可靠检测到亚硝酸盐/硝酸盐。这些发现表明,IL-6通过抑制氧依赖性和未明确的非氧依赖性机制下调M phi抗利什曼原虫能力的细胞因子激活。